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Edited by Stuart FergusonAbstract We have reported previously on the ability of Lacto-
bacillus reuteri to produce a compound with vitamin B12 activity.
Here we report on the chemical characterisation of this corrin-
oid-like molecule. High performance liquid chromatography cou-
pled to an ultraviolet diode array detector, mass spectrometry
and nuclear magnetic resonance spectroscopy has enabled us to
identify the compound as Coa-[a-(7-adenyl)]-Cob-cyanocoba-
mide or pseudovitamin B12. This molecule diﬀers from cobalamin
in the a-ligand, where it has adenine instead of 5,6-dimethylbenz-
imidazole bound in a a-glycosidic linkage to C-1 of ribose.
L. reuteri is the ﬁrst lactic acid bacterium in which the produc-
tion of a cobalamin-like molecule has been identiﬁed and the ﬁrst
microorganism reported to produce exclusively pseudo-B12.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Corrinoids; Lactic acid bacteria; Lactobacillus reuteri1. Introduction
Lactobacillus reuteri is a Gram-positive, heterofermentative
lactic acid bacterium, frequently found in the gastrointestinal
tracts of humans and other animals [1,2]. Relevant probiotic
properties such as the lowering of blood cholesterol levels
[3], and a direct anti-inﬂammatory activity [4–6] have been
demonstrated for this microorganism. During growth on glu-
cose and in the presence of glycerol, L. reuteri possesses the
ability to produce and excrete reuterin [7] (Fig. 1). This broad
spectrum antimicrobial is a mixture of monomeric, hydrated
monomeric and cyclic dimeric forms of 3-hydroxypropionalde-
hyde (3-HPA) [8]. The synthesis of reuterin is mediated by a
B12-dependent enzyme, glycerol dehydratase, which catalyses
the conversion of glycerol to 3-HPA [9].Abbreviations: 3-HPA, 3-hydroxypropionaldehyde; DMB, 5,6-dimeth-
ylbenzimidazole; UV-DAD, ultraviolet diode array detector; pseudo-
B12, Coa-[a-(7-adenyl)]-Cob-cyanocobamide
*Corresponding author. Fax: +31 318 65 04 00.
E-mail address: jeroen.hugenholtz@nizo.nl (J. Hugenholtz).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.09.012We have reported, previously, that a compound isolated in
its cyano form from L. reuteri CRL1098 was capable of fulﬁll-
ing the auxotrophic B12 requirements of three indicator strains
[10]. In the same study, DNA-sequences predicted to encode
enzymes of the anaerobic B12 biosynthesis pathway were iden-
tiﬁed in the chromosome of L. reuteri.
A great variety of vitamin B12 analogues can be found in
nature. They share a structural architecture consisting of a cor-
rin ring with a cobalt ion chelated at the core. Cobalamin, the
best studied corrinoid, is a cobamide in which 5,6-dimethyl-
benzimidazole (DMB) is the aglycon attached to the a-ligand
bound in an a-glycosidic linkage from its N-1 to the C-1 of ri-
bose. B12 biosynthesis is only found in a few prokaryotes [11].
Some have been described to synthesize B12 analogues that
contain bases in the a-ligand other than DMB, namely other
benzimidazoles, purines and phenolic compounds [12].
Here we report on the chemical characterisation of the cor-
rinoid-like molecule isolated from L. reuteri in its cyanided
form. Using high performance liquid chromatography (HPLC)
coupled to an ultraviolet diode array detector (UV-DAD) fol-
lowed by mass spectrometry and nuclear magnetic resonance
spectroscopy, we have concluded that the corrinoid produced
by L. reuteri CRL1098 cultured under anaerobic condition is
pseudovitamin B12. First reported in 1952 by Pﬁﬀer et al.
[13] this B12 analogue diﬀers from cobalamin in the a-ligand,
where DMB appears substituted by adenine. Because the
majority of the structure is conserved, it has been suggested
that this molecule could play a role in assessing the capability
of B12-dependent enzymes to utilize alternative cofactors [14],
and in understanding the impact of B12 analogues in vitamin
B12 metabolism [15,16].
2. Materials and methods
2.1. Preparation of cultures and cell-extracts
A culture of L. reuteri CRL1098 was inoculated in vitamin B12-free
assay medium (Difco), grown at 37 C for 16 h and transferred three
times. Two diﬀerent growth conditions, with and without adding
DMB (100 mg/l), were used in these studies. Cell-extracts were pre-
pared from a 10 L batch culture ﬂushed with a mixture of 95% N2
and 5% CO2, containing approximately 50 lg=L of corrinoid. After
harvesting, cells were washed twice in 0.1 M phosphate buﬀer, pH
7.0, resuspended in 10 mL of extraction buﬀer consisting of 0.1 M
Na2HPO4, pH 4.5 (citric acid) and containing 0.005% KCN. The cell
suspension was separated in 10 aliquots of 1 mL each, disrupted with
1 g of glass beads (0.1 mm diameter) in a FastPrep FP120 (Qbiogene,blished by Elsevier B.V. All rights reserved.
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Fig. 1. Schematic representation of glycerol metabolism in L. reuteri.
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added up to a ﬁnal volume of 20 mL and autoclaved (120 C for
15 min). The mixture was cleared by centrifugation (8000 · g for
10 min), and the supernatant was passed over an Isolute solid-phase
extraction (SPE) column (500 mg C18 end-capped column with a 3-
ml reservoir volume) previously activated with 2 ml of acetonitrile.
The column was washed twice with 2 volumes of distilled water to re-
move salts and other hydrophilic contaminants. Subsequently, the cor-
rinoid was eluted with 1 volume of 50% acetonitrile and concentrated
to dryness in vacuo at 30 C. The residue was dissolved in 5 ml of ster-
ile distilled water and stored in the dark at 20 C until further use.
2.2. Corrinoid isolation
The corrinoid was puriﬁed from cell-extracts of L. reuteri by reverse-
phase high performance liquid chromatography (RP-HPLC) with a
Waters (Milford, MA) 600E system automated gradient controller, a
250- by 3-mm Betasil phenyl column (Thermo Hypersil–Keystone,
Waltham, MA), and a SPD-M10A VP Diode Array Detector (Shima-
dzu Corporation, Kyoto, Japan). The fraction showing a UV-DAD
spectrum similar to that of cyanocobalamin was collected manually
and lyophilised at 30 C.
2.3. Mass spectrometry
The sample collected from the RP-HPLC was dissolved in 100 ll of
an aqueous solution containing 30% acetonitrile and 0.1% formic acid.
Mass spectrometric analyses of the corrinoid puriﬁed from L. reuteri
were performed on a Quatro II triple-quadrupole mass spectrometer
(Micromass, Inc., Altrincham, UK) equipped with an electrospray ion-
ization (ESI) probe, operated in the positive ion mode. Experiments
were carried out under the following conditions: capillary voltage
4.2 kV, cone voltage 36 V, extraction voltage 5 V, source temperature
80 C, desolvation temperature 120 C.
2.4. Nuclear magnetic resonance spectroscopy
Proton nuclear magnetic resonance (1H NMR) spectra were ac-
quired on a Bruker DRX500 spectrometer (Bruker, Rheinstetten, Ger-
many) using a 5 mm inverse-detection probe head. The sample puriﬁed
from the RP-HPLC was lyophilised at 30 C and dissolved in 10%
D2O, which allows the detection of amide resonances. Spectra were re-
corded at 303 K with pre-saturation of the water signal, using an 8.25 s
pulse width corresponding to a 75 ﬂip angle and a repetition delay of
3 s.3. Results
During puriﬁcation, UV-DAD spectra data and retention
times obtained by RP-HPLC analyses showed that L. reuteri
CRL1098 grown under anaerobic conditions produces onemajor cobalamin-like molecule, in a ratio of P100:1 in relation
to other minor corrinoid species. The identiﬁcation and char-
acterisation of the major cobamide produced by this
strain was based on the application of three diﬀerent tech-
niques: RP-HPLC isolation coupled to UV-DAD spectrum
determination, mass spectrometry analysis and NMR spec-
troscopy studies.
3.1. Corrinoid isolation
To isolate and purify the native corrinoid produced by L.
reuteri, cell-extracts were eluted on a C18-SPE column fol-
lowed by RP-HPLC. The cell-extracts from L. reuteri revealed
a peak with a retention time of 36.31 min (Fig. 2A). Although
the peak displayed similar UV-DAD spectra, this retention
time did not agree with the one of the cyanocobalamin stan-
dard (37.83 min). The spectrum of the standard showed a peak
of maximal absorbance at 350 nm and two other at 512 and
550 nm, respectively. The same pattern was observed when
the isolated cobamide produced by L. reuteri was analyzed
(Fig. 2B). Identical chromatography patterns and UV-spectra
were recorded for the corrinoids isolated from L. reuteri
CRL1098 grown in the presence or absence of DMB.
3.2. Mass spectrometry
The mass spectrometry data (Fig. 3) obtained for the corrin-
oid produced by L. reuteri provided evidence that the complete
molecule has a very similar m/z value to the one of methylco-
balamin, 1344.6 and 1344.8, respectively. In both the mass
spectra of the isolated compound and of the standard, the
peaks corresponding to the displacement of both the b-ligand
along with the ribosyl-bound aglycon (m/z 1183.6) and cobina-
mide (m/z 971.6) were identiﬁed. The presence of such peaks in
the mass spectrum of our sample is highly suggestive that it is
indeed a B12 analogue.
However, when all signals displayed on the mass spectra
were considered in detail, the fractions in which only the upper
ligand was not present, revealed a mass variation of 15.1 for
the methylcobalamin standard (m/z 1329.7) and 26.0 for the
isolated compound (m/z 1318.6), corresponding to the dis-
placement of a methyl and a cyano radical, respectively. This
implied that the a-ligand of methylcobalamin and the isolated
compound diﬀered approximately 11 mass units.
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Fig. 2. (A) HPLC chromatogram of the cell-extract and UV-DAD spectrum (inset) of the corrinoid produced by L. reuteri under anaerobic
conditions in the presence of DMB. The same pattern was observed in the absence of DMB. (B) HPLC chromatograms and UV-DAD spectra (inset)
of the puriﬁed corrinoid produced from L. reuteri CRL1098 and the cyanocobalamin standard. Although their retention time does not coincide, both
the spectra of the corrinoid puriﬁed from L. reuteri and the cyanocobalamin standard, display a peak of maximal absorbance at 350 nm and two
other at 512 and 550 nm, respectively.
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ylcobalamin standard, but not in the corrinoid puriﬁed from
L. reuteri. This peak is derived from the lower ligand in which
DMB is the aglycon attached by a glycosyl bound from its N-1
to the C-1 of ribofuranose 3-phosphate. Instead, another peak
is present in the mass spectrum of the corrinoid puriﬁed from
L. reuteri with an m/z value of 348.2, once again implying a
mass variation of approximately 11 in the a-ligand. Further-
more, the peaks with an m/z value of 456.9 and 486.5, corre-
sponding to diﬀerent fractionation in which the corrin ring
and the upper ligand are displaced (Fig. 4A), could be identi-
ﬁed in the methylcobalamin standard but not in the corrinoid
puriﬁed from L. reuteri. Hence, the possibility that the com-
pound produced by L. reuteri had DMB in the lower ligand
was ruled out.
The mass spectrum recorded for the isolated compound
showed a peak corresponding to the sole displacement of
the cyano radical (m/z 1318.6), which was in accordance with
the substitution in the lower ligand of the DMB moiety by
adenine. Also the observed peak with an m/z value of 348.2
corroborated this substitution, and thus, explained the diﬀer-
ence of 11 mass units mentioned above. This observation im-
plied that the corrinoid extracted from L. reuteri was actually
Coa-[a-(7-adenyl)]-Cob-cyanocobamide, commonly known as
pseudo-B12. Furthermore, the observed peaks in the spectrum
with m/z values of 433.3 and 457.1 were consistent with this
proposed structure and represent diﬀerent fragmenting ofthe lower ligand containing adenine instead of DMB
(Fig. 4B).
3.3. Nuclear magnetic resonance spectroscopy
Additionally, a 1H NMR spectrum taken of the corrinoid
puriﬁed from L. reuteri (Fig. 5) showed striking similarities
with published NMR spectra of pseudovitamin B12. In fact,
a comparison between the acquired signals and those obtained
for pseudovitamin B12 by Hoﬀman et al. [17] showed only six
signals that were not present in the published spectrum. How-
ever, these signals are also not present in the spectra of other
corrinoids, and therefore, we have assumed they are caused
either by minor contaminants (peaks marked 2, 4 and 5 in
Fig. 5), or by substances used during sample preparation
(peaks marked 1, 3 and 6 in Fig. 5). Furthermore, the presence
in the 1H NMR spectrum of a characteristic sharp signal
around 8 ppm is indicative of a highly unshielded aromatic
proton in its structure, which, by itself, rules out the identiﬁca-
tion of the corrinoid as cobalamin or factor A, both molecules
lacking such a proton. Pseudovitamin B12, on the other hand,
has such a proton in its structure.
A 1H homonuclear correlation spectrum was recorded and
showed no visible correlations to the three signals at lower-
ﬁeld (8–9 ppm) (data not shown). This is in agreement with
the proposed structure for the a-ligand of the native corrinoid
of L. reuteri, and dismisses the possibility of the presence of
[N8-methyl]-adeninyl-cobamide.
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Fig. 3. (A) Mass spectrometry spectrum of methylcobalamin. The peak with an m/z value of 1344.8 corresponds to the intact molecule; 1329.7
corresponds to the displacement of the upper ligand, the methyl radical; 1183.6 corresponds to the displacement of both the upper ligand and DMB;
971.6 corresponds to cobinamide; 359.3 corresponds to the lower ligand in which DMB is the aglycon attached to ribofuranose 3-phosphate. The
peaks with an m/z value of 486.5 and 456.9 correspond to diﬀerent fractioning in which both the corrin ring and the upper ligand have been displaced.
(B) Mass spectrometry spectrum of the corrinoid puriﬁed from L. reuteri. The peak with an m/z value of 1344.6 corresponds to the intact molecule;
1318.6 corresponds to the displacement of the upper ligand, a cyano radical; 1183.6 corresponds to the displacement of both the upper ligand and
adenine; 971.6 corresponds to cobinamide; 348.2 corresponds to the lower ligand in which adenine is the aglycon attached to ribofuranose 3-
phosphate. The peaks with an m/z value of 457.1 and 433.3 correspond to diﬀerent fractioning in which both the corrin ring and the upper ligand
have been displaced.
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The corrinoid extracted by L. reuteri under anaerobic condi-
tions has been identiﬁed as Coa-[a-(7-adenyl)]-Cob-cyano-
cobamide, commonly known as pseudovitamin B12. The
results obtained performing mass spectrometry and nuclear
magnetic resonance spectroscopy enabled us to identify the
corrin ring with an atom of cobalt at the core, a cyano radical
as the b-ligand, and adenine as the aglycon bound by a glyco-
syl link from its N-1 to the C-1 of the ribose forming the
a-ligand.
During the puriﬁcation of the corrinoid produced by L. reu-
teri, the diﬀerence in retention time between our sample and
the cyanocobalamin standard was suggested to be due to a dif-
ference in the phosphorylation state of the molecule. This was
supported by a previous report on the in vitro synthesis of the
cobalamin nucleotide loop [18], in which, the compound was
identiﬁed as cyanocobalamin-5 0-phosphate using mass spec-
trometry. Based on this, we collected the puriﬁed molecule
with the same UV-DAD spectrum as cyanocobalamin and per-
formed mass spectrometry analysis for molecular characterisa-
tion. Considering all the cobalamin analogues known [12],pseudovitamin B12 was the only one with full spectral consis-
tency based on the mass spectra collected. This analogue has
a structure similar to that of cobalamin except for the lower li-
gand, in which, the DMB moiety is substituted by adenine.
The mass spectrometry results reported here enabled the iden-
tiﬁcation of several peaks corresponding to the fractioning of
the lower ligand containing an adenine base (Fig. 3B). Addi-
tional NMR studies were performed to conﬁrm the identity
of the corrinoid. The conjunction of all the spectral informa-
tion acquired makes it clear that the corrinoid extracted from
L. reuteri was indeed pseudo-B12.
Recently, the gene bluB has been shown to be necessary for
the aerobic biosynthesis of DMB in Sinorhizobium meliloti [19].
It is involved in the fragmentation and contraction of ﬂavin
mononucleotide to form D-erythrose 4-phosphate and DMB
in the presence of oxygen. The recently released genome se-
quence of L. reuteri JCM1112 (DOE Joint Genome Institute,
GeneBank Accession no. CP000705) lacks a homologue of
bluB and the growth of this lactic acid bacterium is impaired
in the presence of oxygen. As a consequence, we consider the
presence of such pathway in L. reuteri to be unlikely. Salmo-
nella enterica has been reported to be able to incorporate exog-
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Fig. 5. Proton nuclear magnetic resonance spectrum of the corrinoid puriﬁed from L. reuteri. 1H NMR spectrum was acquired on a Bruker DRX500
spectrometer using a 5 mm inverse-detection probe head and recorded with presaturation of the water signal, using an 8.25 s pulse width
corresponding to a 75 ﬂip angle and a repetition delay of 3 s. The sample was dissolved in 10% D2O. Peaks marked 1–6 have been assigned to
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F. Santos et al. / FEBS Letters 581 (2007) 4865–4870 4869enous DMB into the lower ligand producing cobalamin [20].
We could not detect a similar behaviour for L. reuteri
CRL1098, which is not completely unexpected. Both pheno-
typically and phylogenetically, these two species are quite dif-
ferent, and thus, it is not surprising that they have diﬀerent
uptake capacities.
Some genera of cyanobacteria have been reported to contain
pseudo-B12 amongst other corrinoids [21,22]. The same applies
to Clostridium cochlearium [17], another Gram-positive bacte-
rium with a low G+C content in its DNA. Interestingly, L. reu-
teri is the ﬁrst microorganism reported to biosynthesize
pseudovitamin B12 as its sole corrinoid product. Pseudo-B12
is not commercially available and until now its supply has so-
lely relied on guided biosynthesis or chemical synthesis [23–25].Vitamin B12 and several of its analogues act as cofactors, cat-
alyzing methyl-transfer and carbon-backbone rearrangement
reactions. The comparison of the cofactor eﬃcacy of the diﬀer-
ent analogues enables the elucidation of complex enzyme–
cofactor interactions. Future studies of the capability of B12-
dependent enzymes to use pseudo-B12 as a cofactor, may rely
on L. reuteri for its provision. Ultimately, this will help in
the eﬀort to elucidate the relevance of the lower ligand and
Co–N coordination for enzymatic activity.
In humans, in vitro studies on B12 binding proteins have
shown that only intrinsic factor can present a real bottleneck
for the uptake of pseudo-B12 [25]. However, comparative
in vivo studies establishing the eﬃcacy of B12 analogues with
a-ligands other than DMB to correct B12 deﬁciency remain
4870 F. Santos et al. / FEBS Letters 581 (2007) 4865–4870to be carried out. L. reuteri is the ﬁrst lactic acid bacterium re-
ported to produce a cobalamin-like molecule. Besides the sys-
tem of producing pseudovitamin B12 characterised here, the
possibility to engineer the production of other corrinoids is
currently under investigation. L. reuteri possesses the GRAS
status (Generally Regarded As Safe), and therefore, could
eventually be used to increase the nutritional value of fer-
mented food and feed products.
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